Azithromycin for improving pulmonary function in cystic fibrosis.
about
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation.Mechanism of azithromycin inhibition of HSL synthesis in Pseudomonas aeruginosaMacrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-gamma stimulated macrophages.Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach.Accumulation of azithromycin and roxithromycin in tracheal epithelial fetal cell lines expressing wild type or mutated cystic fibrosis transmembrane conductance regulator protein (CFTR).Autoinflammatory Disease in the Lung.
P2860
Q33850879-890358A4-2B47-4F1F-B209-3339A14623BDQ36796102-0C0647CA-5825-43B6-A3FF-D876AB03E903Q37959271-1EA74008-5497-4A36-B000-28F88649AADDQ39778460-685429B7-C829-4C33-BC7C-DF3D680D64CCQ42072983-2743F54E-0D76-47E6-85F3-60DA2CBFF278Q46707121-30F57594-EF7E-4369-8D93-16D804B307CDQ52801814-39171745-3C85-4205-B55E-EF81D384EAA6
P2860
Azithromycin for improving pulmonary function in cystic fibrosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Azithromycin for improving pulmonary function in cystic fibrosis.
@ast
Azithromycin for improving pulmonary function in cystic fibrosis.
@en
type
label
Azithromycin for improving pulmonary function in cystic fibrosis.
@ast
Azithromycin for improving pulmonary function in cystic fibrosis.
@en
prefLabel
Azithromycin for improving pulmonary function in cystic fibrosis.
@ast
Azithromycin for improving pulmonary function in cystic fibrosis.
@en
P2860
P356
P1476
Azithromycin for improving pulmonary function in cystic fibrosis.
@en
P2093
Milap C Nahata
P2860
P304
P356
10.1345/APH.1D589
P407
P577
2004-06-22T00:00:00Z